BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3108992)

  • 1. [Occurrence of non-A, non-B post-transfusion hepatitis in heart surgery. Prospective study on the value of the determination of serum alanine aminotransferase and detection of anti-HBc antibodies in blood donors].
    Gayet S; Aymard JP; Janot C; Guillemin C; Briquel ME; Gaucher P; Streiff F
    Rev Fr Transfus Immunohematol; 1986 Dec; 29(6):485-94. PubMed ID: 3108992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients.
    Sugg U; Schenzle D; Hess G
    Transfusion; 1988; 28(4):386-8. PubMed ID: 3133848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.
    Stevens CE; Aach RD; Hollinger FB; Mosley JW; Szmuness W; Kahn R; Werch J; Edwards V
    Ann Intern Med; 1984 Dec; 101(6):733-8. PubMed ID: 6437308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.
    Koziol DE; Holland PV; Alling DW; Melpolder JC; Solomon RE; Purcell RH; Hudson LM; Shoup FJ; Krakauer H; Alter HJ
    Ann Intern Med; 1986 Apr; 104(4):488-95. PubMed ID: 3006567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transfusion non-A, non-B hepatitis after cardiac surgery. Prospective analysis of donor blood anti-HBc antibody as a predictive indicator of the occurrence of non-A, non-B hepatitis in recipients.
    Aymard JP; Janot G; Gayet S; Guillemin C; Canton P; Gaucher P; Streiff F
    Vox Sang; 1986; 51(3):236-8. PubMed ID: 3101289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission.
    Jullien AM; Couroucé AM; Massari V; Maniez M; Finetti P; Brevière D; Girard M; Andréani T; Habibi B
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):668-72. PubMed ID: 8243482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis.
    Takano S; Omata M; Ohto M; Nakamura K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
    Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
    N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study.
    Katchaki JN; Siem TH; Brouwer R; Brandt KH; van der Waart M
    J Virol Methods; 1980 Dec; 2(1-2):119-25. PubMed ID: 7228974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group.
    Blajchman MA; Bull SB; Feinman SV
    Lancet; 1995 Jan; 345(8941):21-5. PubMed ID: 7528310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of alanine aminotransferase and reduction of post-transfusion non-A, non-B hepatitis].
    Hoang B; Simonneau M; Le Xuan P; Guichoux P; Terrier E; Ruffie J
    Rev Fr Transfus Hemobiol; 1989 Apr; 32(2):93-106. PubMed ID: 2502996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors.
    Stevens CE; Taylor PE; Pindyck J; Choo QL; Bradley DW; Kuo G; Houghton M
    JAMA; 1990 Jan; 263(1):49-53. PubMed ID: 2104548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.K. multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I: Alanine transferase and anti-HBc testing.
    Anderson NA; Raafat A; Shwe KH; Barbara J; Contreras M; Fraser ID; Gunson HH; Martlew V; Mijovic V; Goldíe DJ
    Transfus Med; 1992 Dec; 2(4):301-10. PubMed ID: 1285043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated presence of antibody to hepatitis B core antigen in dialysis patients: occurrence of subclinical hepatitis?
    Lai KN; Tam JS; Lai FM; Lin HJ
    Am J Kidney Dis; 1989 May; 13(5):370-6. PubMed ID: 2497642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The declining risk of post-transfusion hepatitis C virus infection.
    Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
    N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B, hepatitis.
    Hoyos M; Sarrión JV; Pérez-Castellanos T; Prieto M; Marty ML; Garrigues V; Berenguer J
    Hepatology; 1989 Mar; 9(3):449-51. PubMed ID: 2493415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
    Gillon J; Hussey AJ; Howe SP; Beckett GJ; Prescott RJ
    Vox Sang; 1988; 54(3):148-53. PubMed ID: 3130726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.